Galderma Laboratories

The Galderma company was formed in 1981 as joint venture Nestlé and L'Oréal. In 2014 Nestle redeemed a share of the partner and created division of Nestle Skin Health. In 2019 Nestle sold an asset and the company began to be called Galderma again.

Assets

For 2014 production capacities of Galderma Laboratories company are distributed between three enterprises. Products of the company are sold more than in 80 countries of the world. Branches are open more than in 40 countries, and the geography constantly extends. The staff of the company totals about 4 thousand employees worldwide.

To Russia supply of medicines is performed from Albi-sur-Sheran (France). Annual average production capacity of it a pharmpredpriyatiya is 30 million units. From there products are also delivered more than to 50 countries of Europe, the Middle East, Africa, Australia and Asia.

Others a pharmpredpriyatiya of Galderma in Montreal (Canada) and Ortolandiya (Brazil) are engaged in production mainly for the markets of the USA and Canada and also the countries of Latin America and Brazil respectively.

About 20% of income are annually invested in opening and development of new medicines and access to advanced technologies. As a result for the last 25 years within research activity of Galderma company 1.7 thousand scientific works are published, more than 500 inventions are registered and 5 thousand national patents are taken out.

Research centers of the company are in France, the USA, Japan. Main, located in the southeast of France in Sophia Antipolis, conducts the main researches of Galderma, preclinical tests and developments. Exactly here the molecule of an adapalen, active ingredient of the medicine "Differin" — basic medicine for outside treatment of an acne was synthesized. Creation of this new modern center of 19.3 thousand sq.m made Galderma company by one of the leading investors in the field of dermatological researches.

Activities

For 2014 the range of medicines of Galderma company includes means for treatment of the most widespread skin diseases:

• acne,
• rozatsea,
• atopic dermatitis,
• onikhomikoz,
• psoriasis and other steroidochuvstvitelny dermatosis,
• non-melanoma cancer of skin,
• violations of pigmentation and
• skin presenilation.

Medicines for treatment of an acne (an acne disease) and conditioning agent behind problem skin are provided by brands:

Baziron AS — medicine of local action for prevention and treatment of an acne. Benzoila the peroxide which is a part of medicine influences bacteria (Propionibacterium acnes and Staphilococcus epidermidis) causing appearance of pimples in comparison with erythromycin, klindamitsiny and azelainovy acid more effectively. Besides, Baziron AS eliminates the become lifeless cages from the surface of skin, suppresses products of skin fat in sebaceous glands and also improves skin oxygenation.

Differin is medicine of the first choice for treatment of a komedonalny form of an acne (an acne disease). Differin deletes mature black points and prevents their development in inflammatory elements — pimples, prevents formation of microcomedones, normalizes processes of a keratinization and epidermalny differentiation, has anti-inflammatory effect on skin.

Setafil is the cleaning lotion developed especially for effective and soft cleaning of sensitive and problem skin of the person from pollution and a make-up. Setafil Dermacontrol — the professional line of care of the problem skin inclined to an acne which includes the moisturizing face treatment with a sun-protection factor SPF 30 and a skin for washing with the physiologic pH level ~ 5.1, the skin providing intensive and long moistening within 24 hours and also considerable decrease in ghost effects of therapy of an acne (reddening, dryness, peeling).

Effezel is medicine for treatment of an acne. Effezel gel 30g contains a combination of an adapalen of 0.1% and benzoit peroxide 2.5%. It is recommended for treatment of an acne, since easy degree. Provides fast effect and long result of treatment. The therapeutic effect develops in 1 — 4 weeks of application. Effezel gel does not cause an antibiotikorezistentnost therefore it can be applied is long.

Lotseril is the only medicine in Russia registered not only for treatment of a fungus of nails, but also for prevention. It is easy and convenient to apply Lotseril — it is applied on nails as normal varnish. Moreover, Lotseril is the only varnish for treatment of a fungus of nails which is applied only once a week. And as the fungus of nails requires long-term treatment (6 — 12 months), convenience of application — the key to success in therapy observance.

For treatment of a rozatse the Galderma company produces the medicine "Rozeks" — one of most innovation topichesky medicines of metronidazole having the special balanced basis which improves capability of active agent to get in skin. It allows to gain necessary therapeutic effect at lower concentration of metronidazole: 0.75% against 1% in analogs. At the same time lower concentration of active ingredient provides higher portability of medicine and minimizes emergence of ghost effects even at prolonged use.

Shower cream gel and the moisturizing Setafil Restoraderm body lotion are developed especially for care of dry, inclined to irritation and atopichny skin, and their efficiency is confirmed by an award from the American Association on atopic dermatitis. Thanks to absence as a part of allergichny parabens and preservatives it is possible to apply means to daily leaving from the first days of life. The producer says that Setafil Restoraderm not just moisturize the skin on a surface, creating a fatty film as the majority of other means, and recover natural process of moistening of skin, forcing skin to work.

Especially for outside therapy of psoriasis of a hairy part of the head of adults specialists of Galderma company developed the Etriveks shampoo supporting a klobetazol propionate of 0.05% — special solving of tasks of the doctor and patient for treatment and prevention of psoriasis of a volosisity part of the head. Medicine eliminates symptoms of psoriasis of a hairy part of the head and increases the remission period.

Metviks — the metilaminolevulinat a hydrochloride, outside application cream, 16% is developed for treatment of non-melanoma cancer of skin by specialists of Galderma company (it is necessary to apply only according to the recommendation of the doctor). Medicine belongs to pharmakoterapevtichesky group of the photosensitizing means. The efficiency of therapy by Metviks cream, according to randomized studies, reaches at a beam keratoz — 88 — 90%, basal and cellular cancer — 91 — 97% and Bowen's disease — 80 — 93%.

History

2019: Nestlé sells the company to consortium of funds for 10.2 billion Swiss francs. The Flemming Ornskov is the new CEO

The Nestle company closed on October 2, 2019 the transaction selling division on production of the dermatological products Nestlé Skin Health which carried out rebranding and again Galderma is called.

In May, 2019 Nestlé announced intention to sell dermatological business. The consortium, the including fund EQT VIII, Luxinva (the subsidiary company which is completely belonging to investment management of Abu Dhabi), PSP Investments and other institutional investors became the buyer. Galderma is sold for 10.2 billion Swiss francs.

New SEO of the company will become Flemming Ornskov, earlier he directed Shire company.

The company performance in Russia is continued as before. Within the global transaction FAS approved sale to the company in July, 2019.

2014: Nestlé purchased Galderma

Nestlé purchased Galderma in 2014, then renamed subsidiary company into Nestlé Skin Health.